Therapeutic plasma exchange an emerging treatment modality: A 3-year retrospective analysis of patients admitted in a multispecialty hospital of North India

被引:1
作者
Solanki, Archana [1 ]
Singh, Ashutosh [1 ]
Chauhan, Abhishek [2 ]
Agarwal, Devisha [3 ]
Himanshu, D. [4 ]
Chandra, Tulika [1 ]
机构
[1] King Georges Med Univ, Dept Transfus Med, Lucknow 226003, Uttar Pradesh, India
[2] Dr RML Inst Med Sci, Dept Radiodiag, Lucknow, Uttar Pradesh, India
[3] King Georges Med Univ, Dept ENT, Lucknow, Uttar Pradesh, India
[4] King Georges Med Univ, Dept Med, Lucknow, Uttar Pradesh, India
关键词
American society of apheresis; citrate anticoagulation; extracorporeal; therapeutic plasma exchange; THROMBOTIC THROMBOCYTOPENIC PURPURA; AMERICAN SOCIETY; APHERESIS; STRENGTH; RECOMMENDATIONS; PLASMAPHERESIS; GUIDELINES; QUALITY; UPDATE;
D O I
10.4103/ajts.ajts_125_20
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND AND AIMS: Therapeutic plasma exchange (TPE) is increasingly used throughout the medical field. We aimed to analyze the various aspects of TPE practices at our hospital in terms of clinical indications, technical feasibility, safety, outcome as well as complications associated with the procedures. MATERIALS AND METHODS: The data included demographic profiles, clinical parameters, and technical characteristics of each TPE procedure. All the information was noted in data spread sheet (Microsoft Excel 2013) for further analysis. RESULTS: This is a 3-year retrospective study of total 266 TPE procedures carried out on 92 patients with different clinical conditions. Out of them, 55 (59.8%) were male and 37 (40.2%) were female patients. There were six major categories such as (1) neurological, (2) hematological, (3) gastrological, (4) renal, (5) rheumatic, and (6) others. The TPE treatment was highest in neurology group (60.2%), followed by gastrology group (24.4%). Most of the procedures (82.6%) were according to the American society of apheresis 2016 I or II categories (76/92 patients). CONCLUSION: TPE is beneficial and used as primary or secondary adjunctive therapy for a wide spectrum of various diseases and syndromes. TPE is considered as safe, cost-effective, and life-saving treatment modality in various diseases.
引用
收藏
页码:46 / 51
页数:6
相关论文
共 28 条
  • [1] Abel JJ, 1914, J PHARMACOL EXP THER, V5, P625
  • [2] Anderson C., 2010, APHERESIS PRINCIPLES, V3rd, P111
  • [3] Chambers HW., 2001, HDB PESTICIDE TOXICO, P1043, DOI DOI 10.1016/B978-012426260-7.50054-9
  • [4] Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange
    Coppo, Paul
    Froissart, Antoine
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 637 - 643
  • [5] Evidence-based guideline update: Plasmapheresis in neurologic disorders Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
    Cortese, I.
    Chaudhry, V.
    So, Y. T.
    Cantor, F.
    Cornblath, D. R.
    Rae-Grant, A.
    [J]. NEUROLOGY, 2011, 76 (03) : 294 - 300
  • [6] Management of acute organophosphorus pesticide poisoning
    Eddleston, Michael
    Buckley, Nick A.
    Eyer, Peter
    Dawson, Andrew H.
    [J]. LANCET, 2008, 371 (9612) : 597 - 607
  • [7] Plasmapheresis in neurological disorders: Experience from a tertiary care hospital in South India
    Gafoor, V. Abdul
    Jose, James
    Saifudheen, K.
    Musthafa, Mohamed
    [J]. ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2015, 18 (01) : 15 - 19
  • [8] Grading strength of recommendations and quality of evidence in clinical guidelines -: Report from an American College of Chest Physicians task force
    Guyatt, G
    Gutterman, D
    Baumann, MH
    Addrizzo-Harris, D
    Hylek, EM
    Phillips, B
    Raskob, G
    Lewis, SZ
    Schünemann, H
    [J]. CHEST, 2006, 129 (01) : 174 - 181
  • [9] GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
    Guyatt, Gordon H.
    Oxman, Andrew D.
    Vist, Gunn E.
    Kunz, Regina
    Falck-Ytter, Yngve
    Alonso-Coello, Pablo
    Schuenemann, Holger J.
    [J]. BRITISH MEDICAL JOURNAL, 2008, 336 (7650): : 924 - 926
  • [10] Adverse events in apheresis: An update of the WAA registry data
    Henriksson, M. Mortzell
    Newman, E.
    Witt, V.
    Derfler, K.
    Leitner, G.
    Eloot, S.
    Dhondt, A.
    Deeren, D.
    Rock, G.
    Ptak, J.
    Blaha, M.
    Lanska, M.
    Gasova, Z.
    Hrdlickova, R.
    Ramlow, W.
    Prophet, H.
    Liumbruno, G.
    Mori, E.
    Griskevicius, A.
    Audzijoniene, J.
    Vrielink, H.
    Rombout, S.
    Aandahl, A.
    Sikole, A.
    Tomaz, J.
    Lalic, K.
    Mazic, S.
    Strineholm, V.
    Brink, B.
    Berlin, G.
    Dykes, J.
    Toss, F.
    Axelsson, C. G.
    Stegmayr, B.
    Nilsson, T.
    Norda, R.
    Knutson, F.
    Ramsauer, B.
    Wahlstrom, A.
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2016, 54 (01) : 2 - 15